Beta test rollout. This site is in community QA — please send feature requests, bug reports and data corrections on the Feedback page or on GitHub.

Home
    Disclaimer
    MGM-15 molecular structure

    MGM-15 Stats & Data

    Dihydro-7-hydroxymitragynine Dihydro-7-OH mitragynine DH7OH MG MGM15
    NPS DataHub
    MW416.52
    FormulaC23H32N2O5
    IUPACmethyl (E)-2-[(2S,3S,7aS,12aR,12bS)-3-ethyl-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate
    InChIKeyQXFXDJATKPXTFF-LIMHOZKTSA-N
    Chemical Class Corynanthe indole alkaloid
    Psychoactive Class Depressant

    Effect Profile

    Curated
    Opioid 6.6

    Strong euphoria with moderate sedation and itching/nausea, mild pain relief

    Euphoria / Warmth×3
    9
    Analgesia×2
    4
    Sedation / Relaxation×1
    7
    Itching / Nausea×1
    6

    Tolerance & Pharmacokinetics

    drugs.wiki
    Half-Life
    Unknown in humans (anecdotal duration suggests multi-hour activity)
    Addiction Potential
    High (opioid-class). Rapid tolerance and dependence are possible with daily use; some users report multiple daily dosing or substitution for other opioids/7-OH.

    No tolerance chart. Our decay curves for opioids were estimates, and a curve can make tolerance look longer-lasting than it is, which is the dangerous direction.

    Opioid tolerance drops fast when you stop, and even a few days off can be enough, so a dose that used to be normal can now stop your breathing. Overdose deaths rise sharply after prison, detox or leaving treatment, and tolerance also falls during a hospital stay. After any break, start with a much smaller amount, try a test dose first, don't use alone, and keep naloxone within reach. Alcohol, benzodiazepines, gabapentinoids and other sedatives make an opioid overdose much more likely.

    Sources: FRANK: heroin · National Harm Reduction Coalition · WHO: opioid overdose · Merrall et al. 2010 · Binswanger et al. 2007 · Strang et al. 2003 · FDA 2019: gabapentinoids and breathing

    Cross-Tolerances

    7-hydroxymitragynine
    mitragynine/kratom
    classical opioids (morphine, oxycodone, fentanyl)

    Harm Reduction

    drugs.wiki

    MGM-15 is a semi-synthetic analogue of the kratom alkaloid 7-hydroxymitragynine (7-OH) developed alongside MGM-16 as mu/delta-opioid dual agonists; animal and in vitro work consistently finds MGM-16 more potent than MGM-15. Human pharmacokinetics for MGM-15 are unknown; harm-reduction dosing must rely on cautious titration and user reports. Duration reported online is often longer than 7-OH (many reporting 6–12 h), which increases overdose risk if redosing too early; establish a hard session limit and wait at least several hours before considering any redose. Do not combine with other depressants; animal data show 7-OH causes naloxone-reversible respiratory depression, so kratom-derived opioids should be assumed capable of dangerous respiratory effects, especially in combinations. Carry naloxone if using opioids; instruct bystanders on overdose response. Product variability is extreme: vendors may sell different salts/purities and the label “MGM-15” can refer to nonidentical products; start low, weigh doses precisely (0.001 g scale) or use volumetric dosing, and avoid eyeballing. Because identity is often uncertain, lab drug checking (e.g., LC–MS/GC–MS) is preferred; reagent kits are presumptive at best and cannot quantify potency. Many report that MGM-15 ‘lasts longer but is less euphoric’ than 7-OH; others report needing much higher doses—likely reflecting tolerance, salt form, and adulteration. Expect opioid-class effects/adverse effects: miosis, pruritus, constipation, nausea, sedation, and potential respiratory depression. If aiming to stop use or transition to buprenorphine, wait for clear opioid withdrawal before induction to avoid precipitated withdrawal; seek medical support. Avoid nasal use; at least one community report describes concerning neurological symptoms after several days of intranasal dosing. For rectal administration, dilute, lubricate, use clean equipment, and avoid frequent redosing to reduce local irritation. Driving or operating machinery while sedated is unsafe; impairment can persist into the next day.

    ← Back to MGM-15